Recent Posts
Recent Comments
Popular Articles
About Uranium Stocks
Uranium Stocks was created to give investors a diversified look at uranium shares, spot prices, options markets, ore and production, canadian reverses and any other relevant issues that may affect shares prices across the globe.
BMO rates Cameco as outperform with a $35 price target
Posted by
webmaster in
BMO sets $35 price target for Cameco
At the tail-end of last week BMO Capital Markets analyst Edward Stereck came out with some bullish comments regarding Cameco Corp.
In Stereck’s commentary for his initiated coverage of Cameco he stated the following:
Cameco’s leading role in uranium production and diversified nuclear asset base makes it well-placed to capitalize on forecast growth in the nuclear industry over the coming years and decades
He rated the stock as outperform and placed a 12 month price target of $35 per share (US). In the report Stereck also stated that the stock is expensive when compared to its peers (listing Paladin) but this premium is acceptable due to the size and market share of Cameco.
With the recent run up in share prices for Uranium stocks across the board a report such as this can only be viewed as positive (for bulls at least) for Cameco and Uranium share holders.